93 related articles for article (PubMed ID: 822138)
1. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid.
Tofe AJ; Francis MD
J Nucl Med; 1976 Sep; 17(9):820-5. PubMed ID: 822138
[TBL] [Abstract][Full Text] [Related]
2. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
Schümichen C; Hohloch M; Hoffmann G
Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
[TBL] [Abstract][Full Text] [Related]
3. Gentisic acid: a new stabilizer for low tin skeletal imaging agents: concise communication.
Tofe AJ; Bevan JA; Fawzi MB; Francis MD; Silberstein EB; Alexander GA; Gunderson DE; Blair K
J Nucl Med; 1980 Apr; 21(4):366-70. PubMed ID: 7381564
[TBL] [Abstract][Full Text] [Related]
4. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two different HEDP content kits: stability study against dilution both in vivo and in vitro.
Inoue O; Ikeda I; Kurata K
Nuklearmedizin; 1982 Jun; 21(3):121-5. PubMed ID: 6813826
[TBL] [Abstract][Full Text] [Related]
6. [Radiochemical purity and stability of Tc-99m-pyrophosphate].
Vucina J
Med Pregl; 2000; 53(9-10):502-5. PubMed ID: 11320732
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo behaviour of four different 99(m)Tc-HEDP complexes.
Inoue O; Yamaguchi T; Ikeda I
Nuklearmedizin; 1982 Dec; 21(6):227-31. PubMed ID: 6820139
[TBL] [Abstract][Full Text] [Related]
8. Effects of prior administration of Sn(II) complexes on in vivo distribution of 99mTc-pertechnetate.
Khentigan A; Garrett M; Lum D; Winchell HS
J Nucl Med; 1976 May; 17(5):380-4. PubMed ID: 1262943
[TBL] [Abstract][Full Text] [Related]
9. [Complexes 99mTc-Sn-DTPA, 99mTc-Fe-ascorbic acid, and 99mTc-Sn-calcium-gluconogalactogluconate in the diagnosis of renal function and morphology (author's transl)].
Licińska I; Graban W; Jakubowski W; Krasucki T; Lachnik E; Wiza J; Zulczyk W; Smoliński S; Zielińska B
Pol Przegl Radiol Med Nukl; 1977; 41(1):57-61. PubMed ID: 859758
[No Abstract] [Full Text] [Related]
10. New preparation method for 99mTc-phytate.
Ikeda I; Inoue O; Kurata K
J Nucl Med; 1976 May; 17(5):389-93. PubMed ID: 1262944
[TBL] [Abstract][Full Text] [Related]
11. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
McRae J; Hambright P; Valk P; Bearden AJ
J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the in vivo properties of 99mTc-HEDP.
Citrin DL
Radiology; 1977 Jan; 122(1):255-8. PubMed ID: 401461
[TBL] [Abstract][Full Text] [Related]
13. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
Kowalsky RJ; Dalton DR
Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m stannous citrate brain-tumor uptake in mice: concise communication.
Haynie TP; Konikowski T; Glenn HJ
J Nucl Med; 1977 Sep; 18(9):915-8. PubMed ID: 893790
[TBL] [Abstract][Full Text] [Related]
15. Distribution of 99mTc-Sn diphosphonate and free 99mTc-pertechnetate in selected soft and hard tissues.
Silberstein EB; Francis MD; Tofe AJ; Slough CL
J Nucl Med; 1975 Jan; 16(1):58-61. PubMed ID: 162948
[TBL] [Abstract][Full Text] [Related]
16. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. II. In vitro studies.
Schümichen C; Mackenbrock B; Hoffmann G
Nuklearmedizin; 1977 Aug; 16(4):157-62. PubMed ID: 198752
[No Abstract] [Full Text] [Related]
18. 99mTc-thiomalic acid complex: a nonstannous chelate for renal scanning.
Hagan PL; Chauncey DM; Halpern SE; Ayres PR
J Nucl Med; 1977 Apr; 18(4):353-9. PubMed ID: 845664
[TBL] [Abstract][Full Text] [Related]
19. Dynamic studies with 99mTc-HEDP in normal subjects and in patients with bone tumors.
Citrin DL; Bessent RG; McGinley E; Gordon D
J Nucl Med; 1975 Oct; 16(10):886-90. PubMed ID: 809552
[TBL] [Abstract][Full Text] [Related]
20. The influence of the method of preparation of the bone scanning agent 99mTc(Sn)EHDP on its tissue distribution in the rat.
Van den Brand JA; Das HA; Dekker BG; de Ligny CL; Van den Hamer CJ
Int J Appl Radiat Isot; 1982 Oct; 33(10):917-28. PubMed ID: 6818161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
